Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis

By sjmartinez • November 11, 2023

Curtis JR, Strand V, Golombek SJ, Karpouzas GA, Zhang L, Wong A, Patel K, Dines J, Akmaev VR. Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis. Rheumatol Ther. 2023 Nov 10. doi: 10.1007/s40744-023-00618-1. Epub ahead of print. PMID: 37948030.

Tags: Harbor UCLA, Molecular signature, Precision medicine, Publications, Response classifier, Rheumatoid arthritis, Rheumatology, Treatment selection

Uptake of Peritoneal Dialysis (PD) by Minoritized Patients: The Role of Modality Education

Arnaoudova I, Wilson C, Rizzolo K, Shen J, Ehtesham N, Wilson J, Golestaneh L. Uptake of Peritoneal Dialysis (PD) by Minoritized Patients: The Role of[...]

Risk factors that predict for presence of clinically significant, noncalcified plaque in younger adults

Mehta A, Thomas F, Manubolu V, Kinninger A, Budoff M, Roy SK. Risk factors that predict for presence of clinically significant, noncalcified plaque in younger[...]

Coronary artery dominance influences the distribution of calcified plaques in the coronary tree

Pourafkari L, Ansari S, Kinninger A, Budoff MJ. Coronary artery dominance influences the distribution of calcified plaques in the coronary tree. Coron Artery Dis. 2025[...]